NL-OMON21428招募中不适用
Intrapulmonal nintedanib distribution in fibrotic interstitial lung disease patients: drug concentrations in lung explantates
Erasmus MC dept. of Medical Oncology and dept. of Pulmonology0 个研究点目标入组 10 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •Patients treated with nintedanib until lung transplantation
排除标准
- •Unwilling to sign informed consent
研究者
相似试验
招募中
不适用
Effects of nintedanib in idiopathic pulmonary fibrosis - analysis on long term prognosis and predictive factorsIdiopathic pulmonary fibrosisJPRN-UMIN000021036ational Hospital Organization Tokyo Medical Center, Department of Respiratory Medicine100
招募中
不适用
Idiopathic Pulmonary Fibrosis treated with Anti-fibrotic Drugs Prospective Observational TrialIdiopathic pulmonary fibrosisJPRN-UMIN000019826HO Kinki-Chuo Chest Medical Center100
尚未招募
不适用
Effect of intrapulmonary administration of recombinant human activated protein C on local coagulation and inflammation after bronchial instillation of lipopolysaccharide in humanspulmonary inflammation and coagulation1000401810024970NL-OMON31950Academisch Medisch Centrum52
招募中
不适用
The Nationwide Survey of Pulmonary Nontuberculous Mycobacteria in JapaPulmonary Nontuberculous MycobacteriaJPRN-UMIN000014936The Study Group of Epidemiology, Diagnosis and Treatment of Nontuberculous Mycobacteria3,000
招募中
不适用
Pulmonary involvement (interstitial lung disease of known etiology) in patients with Seropositive and ACPA positive Rheumatoid Arthritis (RA-ILD I and II)Early detection of lung involvement in RAM05.9M05.1J99.0Seropositive rheumatoid arthritis, unspecifiedRheumatoid lung diseaseDRKS00028871Boehringer Ingelheim Pharma GmbH & Co. KG200